Compare HRL & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRL | MEDP |
|---|---|---|
| Founded | 1891 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Meat/Poultry/Fish | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 13.4B |
| IPO Year | N/A | 2016 |
| Metric | HRL | MEDP |
|---|---|---|
| Price | $24.48 | $543.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 12 |
| Target Price | $28.67 | ★ $465.18 |
| AVG Volume (30 Days) | ★ 5.4M | 277.0K |
| Earning Date | 12-04-2025 | 10-22-2025 |
| Dividend Yield | ★ 4.81% | N/A |
| EPS Growth | N/A | ★ 25.36 |
| EPS | 0.87 | ★ 14.32 |
| Revenue | ★ $12,106,160,000.00 | $2,358,373,000.00 |
| Revenue This Year | $3.46 | $21.48 |
| Revenue Next Year | $2.75 | $11.90 |
| P/E Ratio | ★ $28.00 | $38.28 |
| Revenue Growth | 1.55 | ★ 13.88 |
| 52 Week Low | $21.03 | $250.05 |
| 52 Week High | $33.80 | $626.26 |
| Indicator | HRL | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 69.24 | 36.48 |
| Support Level | $22.85 | $530.96 |
| Resistance Level | $25.30 | $626.26 |
| Average True Range (ATR) | 0.48 | 18.24 |
| MACD | 0.25 | -8.14 |
| Stochastic Oscillator | 71.41 | 17.60 |
Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (62% of fiscal 2024 sales), US foodservice (32%), and international (6%). By product, 72% of fiscal 2024 sales were from perishable food and 28% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.